Skip to content

Addiction research published in 2015

Page 2 of 2: studies 21 to 22 of 22, newest first. Back to the addiction overview

Studies

Can psychedelic compounds play a part in drug dependence therapy?

The British Journal of Psychiatry 2015 Ben Sessa, Matthew W. Johnson 58 citations

Summary After a 40-year hiatus there is now a revisiting of psychedelic drug therapy throughout psychiatry, with studies examining the drugs psilocybin, ketamine, ibogaine and ayahuasca in the treatment of drug dependence. Limitations to these therapies are both clinical and legal, but the possibility of improving outcomes for patients with substance dependency imposes an obligation to research...

Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders.

Frontiers in Pharmacology 2015 Eduardo R Butelman, Mary Jeanne Kreek 3 citations correction

In the original review, we placed an incorrect citation in a sentence. The correct sentence and citation are as follows: "Also, salvinorin A can act as a “punisher” to self-administration of cocaine or a short-acting MOPr agonist in primates (when given contingently; Freeman et al., 2014).” The authors apologize for the mistake. This error does not change the scientific conclusions of the...